Anticipating The Powerful Advance In Gilead Sciences (GILD)
by Mike Paulenoff
October 30, 2022 • 4:32 PM EDT
Back on August 29, Mike Paulenoff alerted MPTrader members to his excitement about the potential for a powerful advance in Gilead Sciences (GILD), writing:
For two years, GILD has been traversing a wide (24%) range between 57-59 on the low side and 70-72 on the high side (see my attached Daily Chart). Every time GILD sinks into the vicinity of 60, it becomes relatively cheap within the range (57 stop) ahead of a traverse towards 70-72... If you are a VERY PATIENT investor who does not mind tying up money for an extended period of time, then you are risking a close under 56.50 to "be there" for the run to and above 69.00-70.00, and thereafter, towards a challenge of the upper boundary zone from 83 to 87, where GILD either will rocket into a new bull leg, or fail miserably.
My sense from the very BIG picture structural setup since 2010 is that since 2017 GILD has been biding time ahead of a forthcoming VERY BULLISH direction price catalyst (or catalysts) that will propel the stock out of its rangebound funk... Last is 62.56.
Fast-forward to last week in which indeed a catalyst unleashed GILD's bullish potential. It turned out to be a Q3 Earnings Report that far exceeded Wall Street's expectations, and as such, triggered an extremely positive investor reaction that propelled the stock above a 2-1/2 year resistance plateau from 72 to 74, toward Mikes intermediate-term target zone of 83 to 87.
GILD closed at 79.27 on Friday, a full 27% above its price when Mike first alerted MPTrader members on August 29.
What's next for GILD and other names and ETFs in the Biotech and Healthcare space? Join Mike and MPTrader members for their constant intraday market discussions about individual stocks, ETFs, Macro Indices, Commodities, Crypto, and much more, especially during the forthcoming consequential Fed Week!
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
Last Thursday (4/17/25) afternoon, ahead of NFLX (Netflix) post-close earnings report and the three-day Good Friday holiday weekend, we discussed the technical setup and whether or not the NFLX pattern was positioned to react positively to the news : The NFLX setup heading into Earnings later today is favorable for upside continuation above the prior two rally highs at 993.45 (4/15) and 998.70 (3/25), but not to a new ATH above 1064.
Last Thursday afternoon (4/10/25), the commentary below is what I discussed with MPTrader members about my Big Picture technical setup work: Tomorrow is the final session of the week. We get some big bank Earnings and PPI before the open, and more than likely, one or more POTUS televised events that undoubtedly will move markets one way or other. Technically, tomorrow's (Friday) close will be important to my Weekly Chart Work.
At the beginning of last week, fellow members Rayray and GordonGekko asked for my technical setup work on BX (Blackstone Inc). This is what we discussed on the morning of March 25, 2025:My attached Daily Chart shows the November 2024 to mid-March 2025 correction (-32%) followed by the recovery rally from 135.60 to 153.18.
On March 10, 2025, fifteen minutes before the closing bell and Oracle's forthcoming Earnings Report, below was the analysis I posted to the MPTrader Discussion Room about ORCL:"... My preferred scenario indicates a negative reaction to the news that sends ORCL reeling to test important support at 139.50-141.20-- where ORCL MUST reverse to the upside to avert triggering still lower projections into the 118-123 (back the truck up) target window... Last is 149.32"...
Last October 21, 2024, I alerted MPTrader members to a Goldman Sachs upgrade of optical products retailer Warby Parker (WRBY) to Buy from Neutral. Goldman attached an 18.00 target price to the stock. At the time of my post to members, WRBY was trading at 17.55 in reaction to the GS upgrade, up 6% from the prior close, and just 2.5% from Goldman's 12-month target price.
